1. HBW Insight
  2. >>Wellness
  3. >>Policy & Regulation

Bausch Health's Securities Litigation Casts Shadow Over B+L's Future As Independent Firm

 
• By Malcolm Spicer

For all B+L has going for it, including consumer health eye health and vision care products as its sales driver, it could be stymied by investors alleging Bausch Health conducted fraudulent conveyance by spinning out B+L through an IPO in 2022.

• Source: Shutterstock

Bausch + Lomb Corp.’s latest results coming on 3 May will mark the start of its second year operating independently of former parent firm and still majority owner Bausch Health Companies Inc. But the Canadian firm’s independence is under challenge.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation